Latest Articles

Advancing therapy in suboptimally controlled basal insulin-treated type 2 diabetes: Clinical outcomes with iGlarLixi versus premix BIAsp 30 in the SoliMix randomized controlled trial.

Prolonged Thromboprophylaxis with LMWH after Abdominal or Pelvic Surgery

Maternity Clot Risk Model to Predict Women at Risk of VTE

Independent Risk Factors for Venous Thromboembolism

VTE Comparison of Pregnancy - Specific Risk Scoring Systems in Hospitalized Maternity Patients

Large prospective clinical trials are needed to validate the scoring threshold for pharmacoprophylaxis.

Utility of Pregnancy - Adapted Years Algorithm in Diagnosis of Pulmonary Embolism

Findings from a multicentre prospective Artemis study.

Trends in Pulmonary Embolism-related mortality in Europe

An analysis of vital registration data from the WHO Mortality Database (2000-2015).

Specific Patient Characteristics Linked to Below Average Quality of Life in Patients with Recent Venous Thromboembolism (VTE)

Many associated factors are modifiable indicating potential benefit from planned strategies.

Risk for Pulmonary Embolism Continues Beyond 6 Weeks of Surgery

Guidelines recommend postoperative prophylactic anticoagulation for 1-5 weeks.